Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate

Author:

Gendrot Mathieu,Duflot Isabelle,Boxberger Manon,Delandre Océane,Jardot Priscilla,Le Bideau Marion,Andreani Julien,Fonta Isabelle,Mosnier Joel,Rolland Clara,Hutter Sébastien,La Scola Bernard,Pradines Bruno

Funder

he Institut Hospitalo-Universitaire

ational Research Agency

L’Occitane Society.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference29 articles.

1. Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine;Ali;Malar J,2010

2. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infection diseases referral hospital in Marseille, France, -January 31 to March 1, 2020: A respiratory virus snapshot;Amrane;Travel Med Infect Dis,2020

3. In vitro testing of hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect;Andreani;Microb Pathog,2020

4. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria;Ashley;Trop Med Int Health,2007

5. Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice;Barnard;Antivir Chem Chemother,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3